| # | Drug | Count |
|---|---|---|
| 0 | AMOXICILLIN | 8 |
| 1 | CALCIUM | 8 |
| 2 | PREDNISONE | 8 |
| 3 | ACETAMINOPHEN | 7 |
| 4 | CISPLATIN | 5 |
| 5 | DENOSUMAB | 5 |
| 6 | DEXAMETHASONE | 5 |
| 7 | DEXAMETHASONE 1.5 MG | 5 |
| 8 | METHYLPREDNISOLONE SODIUM SUCCINATE | 5 |
| 9 | MYCOPHENOLATE MOFETIL | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MINOXIDIL TOPICAL SOLUTION | 1 | 0.1429 |
| 1 | CORTISOL | 1 | 0.0025 |
| 2 | DESONIDE | 4 | 0.0008 |
| 3 | NARATRIPTAN | 1 | 0.0007 |
| 4 | CAPLACIZUMAB | 1 | 0.0006 |
| 5 | RYDAPT | 1 | 0.0005 |
| 6 | DACTINOMYCIN | 1 | 0.0005 |
| 7 | ESOMEPRAZOLE SODIUM | 1 | 0.0004 |
| 8 | APREPITANT | 3 | 0.0004 |
| 9 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 12 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 2 | Calcium [EPC] | 8 |
| 3 | Platinum-based Drug [EPC] | 8 |
| 4 | Kinase Inhibitor [EPC] | 7 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 6 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 5 |
| 7 | RANK Ligand Inhibitor [EPC] | 5 |
| 8 | Amide Local Anesthetic [EPC] | 4 |
| 9 | Anti-epileptic Agent [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | Actinomycin [EPC] | 1 | 0.0005 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 3 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 4 | Progesterone [EPC] | 4 | 0.0002 |
| 5 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 6 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 8 | Ester Local Anesthetic [EPC] | 4 | 0.0001 |
| 9 | Calcium [EPC] | 8 | 0.0001 |